Sunday, July 7, 2013

Quarterly interest means depositors lose Rs 2500 crore per year - Interesting Article

Source: Economic Times

Depositors are losing close to Rs 2,500 crore every year because of Indian banks applying interest on deposits every quarter instead of every month, according to a report by the Indian Institute of Technology, Mumbai. This is in contrast to loans where interest is applied on a monthly basis.

To study the impact of this discrimination, one needs to compare the interest liability on a Rs 1 lakh education loan at the end of the year compared to earnings from a fixed deposit assuming interest on both was 10%. While the interest earned on the FD would be around Rs 10,381, the interest liability on the loan would be Rs 10,471. Such comparison is only possible in education loans where there is no repayment in the first year.

At present, the Reserve Bank of India (RBI) mandates banks to apply interest on deposits at quarterly or larger intervals. Banks also calculate interests accrued on a fortnightly basis but only for reporting to RBI.

The technical report by Ashish Das from IIT's mathematics department published this week is expected to be taken seriously by RBI, considering that the central bank itself had raised the issue in the past. The report, titled 'Interest of bank depositors in chaos', has studied interest application frequency on bank deposits and the methodology used by banks in calculating interest income.

The regulator also paid heed to earlier reports from the same author, which resulted in regulatory changes including recommendation that banks apply interest on daily balances in savings deposits. A subsequent paper had suggested that RBI directs banks to reduce fees charged to merchants for settling payments from debit cards since banks were merely transferring funds from customer accounts and not providing a loan to the cardholder as was happening in credit cards.

"The application of interest at six monthly rests has been more of a legacy. It was more from the ease and convenience of interest computation at the pre-computer era. Such a scenario no longer exists since the country today has a satisfactory level of computerization in commercial banks," said Das. The report points out that because of lax regulation some banks such as HDFC Bank (effective April 2011) moved from their earlier quarterly application of interest to half yearly application. "Such a move, though beneficial to the banks, is at the cost of their SB depositors," the report said.

If banks were directed to apply interest at the end of every month, the return for the depositor would rise by a around Rs 90 for someone with a Rs 1 lakh FD.

At a systemic level, total savings to banks runs into crores considering that there are 800 million bank accounts with Rs 15.5 lakh crore in savings accounts and Rs 45 lakh crore in FDs.

The study also finds that the amount of tax deducted at source can come down by Rs 400 to Rs 500 crore if banks applied TDS at the end of the financial year and paid the amount out of savings account rather than charging it to the fixed deposit.

15 comments:

  1. Close to 2 lakh shares have been bought back by Infinite Computers so far...
    You can check the details over here:
    http://www.nseindia.com/corporates/corporateHome.html?id=eqCorpAnnouncementsNav

    Use filters to check it only for Infinite Computers, and for last 1 month...

    ReplyDelete
  2. In the meanwhile, Thangamayil continues to impress with its increasing number of branches...

    Opening of 31st New Branch at Villupuram - Tamilnadu
    Thangamayil Jewellery Ltd has informed BSE that the Company is opening its 31st branch at Villupuram on July 10, 2013 between 09.00am and 10.00 am Admeasuring 1960 sqft.

    ReplyDelete
  3. Interestingly, today, I found a blog which is personal to and has all information about Money Matters...
    http://money-mattersindia.blogspot.in/

    ReplyDelete
  4. Ajanta Pharma, with its performance, off-late is showing signs of going into over-valued category..
    The stock is already trading at a P/E ratio of 24.5, which is high compared to other small cap or midcap pharma stock....
    What this means now, is that they will have to post very robust numbers going ahead for every quarter to hold onto these levels or may be still go ahead....
    If the price has to remain at levels above 1000, then company needs to post an EPS of atleast 65 or so for FY14....
    Right now, lets maintain a wait and watch strategy..

    ReplyDelete
  5. Outcome of Share Transfer and Shareholders / Investors Grievance Committee Meeting:

    Granules India Ltd has informed BSE that the Share Transfer and Shareholders / Investors Grievance Committee at their meeting dated July 11, 2013 have approved to allot 72,000 equity shares in consequent to exercise of options under ESOP 2002 & ESOP 2009.

    ReplyDelete
  6. Money Matters- Result of Postal Ballot:

    http://www.moneycontrol.com/livefeed_pdf/Jul2013/Money_Matters_Financial_Services_Ltd_110713.pdf

    ReplyDelete
  7. Money Matters Financial Services will infuse Rs 25 crore as its initial capital contribution in the proposed realty-focused asset management company (AMC).

    The realty AMC will have an initial capital of Rs 50 crore to start with, P. H. Ravikumar, Managing Director, Money Matters Financial Services (MMFS), told Business Line here.

    This AMC will be a 50:50 joint venture between MMFS and Chicago-based Capri Capital partners.

    Ravikumar pointed out that SEBI has now revised the minimum capitalisation level for AMCs to Rs 50 crore.

    So the joint-venture partners have decided to begin the AMC journey with an initial capital of Rs 50 crore, with each side pitching in Rs 25 crore.

    Meanwhile, the shareholders of MMFS , a listed non-banking finance company, have approved name change of the company to Capri Global Capital Ltd.

    MMFS has also now filed the application for name-change with the Registrar of Companies, Ravikumar said.

    He was hopeful that approval from the Registrar of Companies will be in place by end-July or mid-August.

    Money Matters and Capri Capital Partners are already in talks to see how the latter could participate in the equity capital of the non-banking finance company.

    Quintin E. Primo III, Chairman and Chief Executive Officer of Capri Capital Partners, will be offered a director’s seat on the board of Money Matters, it is learnt.

    MMFS is currently focused on loans to small enterprises and real-estate development.

    By March 2014, MMFS expects its small enterprises’ loan book to be bigger than the real-estate book

    Source: Business Line

    ReplyDelete
  8. Stocks of housing finance cos a good hedge against volatility?

    Shares of housing finance companies may offer a good hedge against volatility, say experts.

    Analysts are upbeat on India's housing finance industry that disbursed loans worth R2,10,000 crore last fiscal (2012-13) and is likely to grow 20% per annum for the next five years.

    The optimism has shown its effect on the bourses as well, with stocks of housing finance firms including HDFC, LIC Housing Finance and Dewan Housing Finance generating 19-20% returns in last couple of month.


    “The prospects of this industry are very bright,” said Anil Kothuri, head, Edelweiss Housing Finance. “Demand is projected to grow 20% per annum at least for the next five years.”

    “The Indian housing finance sector has a long track record of shareholder value creation based on excellent borrower behaviour and largely secular growth in assets,” say ICICI Securities analysts Santanu Chakrabarti, Ujjwal Somani and Shashin Upadhay in a report on housing finance companies.

    Going forward, the sector offers tremendous opportunities, feel experts. While the market size of urban affordable housing is around R7 trillion, that of rural housing is R5 trillion. And the shortage of 2 crore houses in India is only likely to fuel growth.

    “The increasing nuclearisation of the family will contribute to the demand for more houses in the country, which means that the demand for housing finance will grow,” said Kothuri.

    But will sluggish demand for real estate in the country hit the housing finance industry?

    Yes, feel experts, since property prices remain the key driver for the sector's performance.

    “Any major correction in property prices could possibly result in asset quality challenges for players, while any significant increase in prices could reduce affordability, thereby impacting the sector’s loan growth potential,” said Vaibhav Agrawal, vice-president, research and banking, Angel Broking.

    Similarly, government policies, especially those related to tax deductions for home loan borrowers and the interest rate scenario are also going have an impact. The average rate of interest currently stands at 10.5%.

    “However, recent regulatory changes such as abolition of pre-payment penalty and expectations of a fall in borrowing costs are likely to provide some near-term benefits,” I-Sec analysts said.

    They recommend a buy on HDFC (target price of R900), LIC Housing Finance (target price of R360) and Dewan Housing Finance (target price of R350).

    Source: Hindustan Times

    ReplyDelete
  9. Suven Life Sciences to Present at Alzheimer's Association International Conference

    Several exciting new results and data presentations from Suven Life Sciences Ltd's portfolio of investigational neuroscience new chemical entities (NCEs) are being presented at Alzheimer's Association International Conference (AAIC) being held in in Boston, USA during July 13-18, 2013.

    AAIC is the world's largest conference of its kind, bringing together researchers from around the world to report and discuss groundbreaking research and information on the cause, diagnosis, treatment and prevention of Alzheimer's disease and related disorders.

    Alzheimer's disease is one of the scourges of modern day health care which is the largest and fastest growing unmet medical need and Suven is in the forefront of developing a drug for the treatment of this debilitating disease. Alzheimer's is a dementia that causes problems with memory, thinking and behavior. Alzheimer's is not just a memory loss as everyone thinks but Alzheimer's kills.

    Suven has excellent portfolio of new molecules through four mechanisms of action using 5-HT6, 5-HT4, H3 and Neuronal Nicotinic acetylcholine receptors for the treatment of cognitive impairment in Alzheimer's disease symptomatically but also possibly useful in reducing the disease progression. Suven scientists are presenting pre-clinical and clinical data on these molecule and other NCEs on cognitive impairment and memory related disorders.

    Shares of Suven Life Sciences Ltd was last trading in BSE at Rs.24.65, down by Rs.0.85 or 3.33%. The stock hit an intraday high of Rs.25.90 and low of Rs.24.55.

    The total traded quantity was 0.41 lakhs compared to 2 week average of 0.58 lakhs.


    Source: Equity Bulls

    ReplyDelete
  10. Kindly throw some light on what the management of granules india doing by pledging then buying then pledging again... Is interest of minority share holders still intact?
    Regards

    ReplyDelete
  11. Hey Anand,

    We can comment unless we know the reasons of pledging by Promoters. Its not always that pledging by promoters is considered to be bad for the investors, unless we know the reason behind it.

    The last time Mr Krishna Prasad pledged his shares, he finally used that funds to buy more shares from open market (Just a speculation from my side), then there is no problem, as we should not forget the fact that, in case of pledging, the Share Holding of that promoter does not go down. The holding is intact. Hence if he takes loan from some financial institute to buy more from open market then nothing could be better.
    But this time, probably it is not going to be that same scenario, as the promoters have already accumulated 5% shares from open market. Lets keep a wait and watch strategy and stick to our plan of long term investment.
    We will have a relook quarter after quarter, as one should also not forget the fact that, the utilization of expansion is going to be progressive and not like everything at one go. They are working to get approvals from their client, and accordingly working on expanded capacity.

    I am hopeful in this case, because the stock has hold onto 130-140 levels for some time, which represents around 30-40% appreciation from last quarter numbers.

    ReplyDelete
  12. Today we have another report, which is in contradiction to few reports earlier, where promoter has actually released 3 Lakh shares from pledge.

    http://www.bseindia.com/xml-data/corpfiling/AttachLive/Granules_India_Ltd_170613_SAST.pdf

    Now, the best I think at this stage, is to forget about the small moves by the management and lets concentrate on upcoming results, and few good announcements to go with it.

    Btw, Granules is coming out with Q1 numbers on 25th July....

    ReplyDelete
  13. But at the end of the day, I consider if the promoters are frequently trading in the market it is bad for the confidence of investors as we have seen in couple of shares where they never released the shares and company almost became bankrupt as far as share price is concerned, Zylog Systems, Transgene biotech, etc. In fact, retail investor has to keep constant eye on promoters' moves. Consider a situation, where promoters have constantly bought shares from the market and shore up the share price and on the back-end very very substantial quantity has been pledged taking advantage of the elevated levels of share price. They don't mind loosing control of the company because they are well aware of the internal position of the company and it's valuations !!!!

    ReplyDelete
  14. Ajanta Pharma Ltd has informed BSE that a Meeting of the Board of Directors of the Company will be held on July 29, 2013:

    1. To consider and approve, inter alia, the Unaudited Financial Results for the first quarter ended June 30, 2013.

    2. To consider Bonus issue of shares.

    ReplyDelete
  15. Hey totalview,

    I dont deny what you said, but dont you think, its too early to think this way for Granules?
    I am saying this because, unlike Zylog, promoters have never sold shares in open market in past 2 years....
    On the contrary, they have accumulated 5% shares from open market since last 2 years.

    I have been tracking this stock since last August, and believe my words, they were not at all involved in trading so much. Off-late we have seen this happen time and again...

    But as you said, definitely, we will keep an eye on their moves, as well as numbers posted by the company.

    ReplyDelete